Mechanistic insights of inflammation and organ failure after trauma or critical illness
Mechanistic insights of inflammation and organ failure after trauma or critical illness
批准号:
9894815
负责人:
Yang Jin
金额:
$31.35万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-04-01 至 2022-03-31
关键词:
AcidsAcute Lung InjuryAdult Respiratory Distress SyndromeAlveolarAlveolar CellAlveolar MacrophagesAnesthesia proceduresAspirate substanceBronchoalveolar Lavage FluidCaveolinsCellsCharacteristicsComplexCritical CareCritical IllnessDataDevelopmentDiagnosticDistressEdemaEncapsulatedEndotheliumEpithelialEpithelial CellsEpitheliumEsophagusEventExposure toHyperoxiaIn VitroInfectionInflammationInflammatoryInflammatory ResponseLungLung InflammationMacrophage ActivationMediatingMedicineMembrane MicrodomainsMethodsMicroRNAsModelingModificationMusNatural ImmunityOrgan failureOxygenPathogenesisPatientsProteinsPublishingPulmonary InflammationRNARegulatory PathwayReportingResearchRespiratory FailureRoleSerumSignal PathwaySignal TransductionSterilityStimulusStomachSyndromeTestingTherapeuticTraumaWorkalveolar epitheliumbasecaveolin 1clinically significantextracellular vesiclesfallsin vivoinnovationinsightintercellular communicationmacrophagemicrovesiclesmigrationmortalitynext generation sequencingnovelnovel diagnosticsnovel therapeuticspost-traumarecruitresponsesevere injurysystemic inflammatory response
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract/Summary
Aspiration of non-infectious gastro-esophageal contents and/or exposure to high concentrations of
supplemental oxygen are common events in trauma, anesthetized and/or other critically ill patients. Some of
these patients will develop a more serious and protracted pulmonary or systemic inflammatory response leading
to acute lung injury (ALI) or worse, acute respiratory distress syndrome (ARDS). Despite recent advances in
critical care medicine, overall mortality from ARDS remains unacceptably high, reflecting the lack of specific
therapies. Currently, the pathogenesis of this devastating syndrome remains incompletely understood,
particularly after the “non-infectious” or “sterile” stimuli as mentioned above.
The characteristic features of ALI/ARDS include an intense inflammatory response, severe injury to the
epithelial / endothelial barrier and alveolar edema. Recent evidence suggests that type I alveolar epithelial (ATI)
cell have previously unrecognized functions in innate immunity and are underappreciated players in lung cell-
cell cross-talk. Based on our published and preliminary data, we propose that ATI cell-derived microvesicles
(ATI-MVs) mediate the intercellular communication between ATI cells and alveolar macrophages (AMs) by the
shuttling of selective miRNAs, thus broadcasting distress signals to the recipient cells and initiating the
inflammatory cascades.
In our previous work, we have reported that epithelial extracellular vesicles (EVs) are inducible and detectable
in both mouse broncho-alveolar lavage fluid (BALF). After exposure to aspirated acid or hyperoxia (sterile
model of ALI), most of the induced E Vs originate from living ATI epithelial cells and fall into the range of
microvesicles (MVs). We further showed that MV-shuttling miRNAs promoted classic macrophage activation
and migration in vitro and lung inflammation in vivo. Lipid raft protein caveolin-1 (cav-1) facilitates the selection
of miRNA complex in the MVs. Based on our published and the supporting data, we hypothesize that the type I
alveolar epithelial MVs mediate non-infectious stimuli-associated inflammation via promoting macrophage
activation and recruitment through MV-miRNAs. We also hypothesize that the stimuli-induced cav-1 /
hnRNPA2B1 interaction and modification regulate the incorporation of selective miRNAs into MVs. We will test
our hypotheses in the following specific aims. In aim I: we will characterize the secretion of MV-miRNAs and their
target cells in the presence of non-infectious stimuli. In aim II, we will determine the mechanisms of the miRNA
selection in MVs. In aim III, we will determine the functions of MV-miRNAs after non-infectious stimuli.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LncRNA regulates lung inflammation
-
批准号:10434036
-
项目类别:
-
资助金额:$49.16万
-
财政年份:2019
-
负责人:Yang Jin
-
依托单位:
LncRNA regulates lung inflammation
-
批准号:10205157
-
项目类别:
-
资助金额:$49.16万
-
财政年份:2019
-
负责人:Yang Jin
-
依托单位:
LncRNA regulates lung inflammation
-
批准号:10001992
-
项目类别:
-
资助金额:$49.16万
-
财政年份:2019
-
负责人:Yang Jin
-
依托单位:
Mechanistic insights of inflammation and organ failure after trauma or critical illness
-
批准号:10393782
-
项目类别:
-
资助金额:$0.97万
-
财政年份:2018
-
负责人:Yang Jin
-
依托单位:
Mechanistic insights into the systemic inflammation and organ failure in sepsis
-
批准号:9063433
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2014
-
负责人:Yang Jin
-
依托单位:
Mechanistic insights into the systemic inflammation and organ failure in sepsis
-
批准号:9276750
-
项目类别:
-
资助金额:$31.26万
-
财政年份:2014
-
负责人:Yang Jin
-
依托单位:
Cross talk between cav-1 and flot1 in lung injury
-
批准号:8107341
-
项目类别:
-
资助金额:$41.59万
-
财政年份:2011
-
负责人:Yang Jin
-
依托单位:
Cross talk between cav-1 and flot1 in lung injury
-
批准号:8265608
-
项目类别:
-
资助金额:$43.06万
-
财政年份:2011
-
负责人:Yang Jin
-
依托单位:
Cross talk between cav-1 and flot1 in lung injury
-
批准号:8431403
-
项目类别:
-
资助金额:$41.36万
-
财政年份:2011
-
负责人:Yang Jin
-
依托单位:
Cross talk between cav-1 and flot1 in lung injury
-
批准号:8645699
-
项目类别:
-
资助金额:$42.96万
-
财政年份:2011
-
负责人:Yang Jin
-
依托单位:
Cross talk between cav-1 and flot1 in lung injury
-
批准号:9181729
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2011
-
负责人:Yang Jin
-
依托单位:
Regulation and function of Cyr61 in hyperoxia induced acute lung injury
-
批准号:7664946
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2006
-
负责人:Yang Jin
-
依托单位:
Regulation and function of Cyr61 in hyperoxia induced acute lung injury
-
批准号:7904906
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2006
-
负责人:Yang Jin
-
依托单位:
Regulation and function of Cyr61 in hyperoxia induced acute lung injury
-
批准号:7478544
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2006
-
负责人:Yang Jin
-
依托单位:
Regulation and function of Cyr61 in hyperoxia induced acute lung injury
-
批准号:7260355
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2006
-
负责人:Yang Jin
-
依托单位:
Regulation Cyr61 in hyperoxia induced acute lung injury
-
批准号:7138358
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2006
-
负责人:Yang Jin
-
依托单位:
Regulation and Function Cyr61 in Acute Lung Injury
-
批准号:6995914
-
项目类别:
-
资助金额:$5.33万
-
财政年份:2005
-
负责人:Yang Jin
-
依托单位:
海外基金